Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Common-Size Balance Sheet: Assets

Boston Scientific Corp., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Cash and cash equivalents 2.86 5.97 5.63 0.71 0.70
Trade accounts receivable, net 6.07 5.52 4.97 5.98 7.66
Inventories 5.75 5.00 4.39 5.17 5.55
Prepaid income taxes 0.81 0.64 0.63 0.64 0.77
Assets held for sale 0.00 0.00 3.68 0.00 0.00
Restricted cash and restricted cash equivalents 0.46 0.58 0.68 1.13 3.12
Derivative assets 0.71 0.70 0.43 0.34 0.58
Licensing arrangements 0.18 0.41 0.48 0.61 0.00
Other 0.89 0.79 0.85 0.80 0.69
Other current assets 2.25% 2.48% 2.44% 2.88% 4.39%
Current assets 17.74% 19.60% 21.75% 15.37% 19.06%
Property, plant and equipment, net 7.53 6.99 6.77 6.80 8.49
Goodwill 39.79 37.20 32.33 33.29 37.67
Other intangible assets, net 18.18 18.99 19.23 25.80 30.34
Deferred tax assets 12.14 12.85 13.68 13.73 0.41
Restricted cash equivalents 0.15 0.17 0.17 0.14 0.13
Operating lease right-of-use assets 1.19 1.35 1.49 1.10 0.00
Derivative assets 0.46 0.52 0.35 0.71 0.87
Investments 1.25 1.28 2.98 1.50 2.02
Licensing arrangements 0.21 0.35 0.71 1.09 0.00
Indemnification asset 0.53 0.00 0.00 0.00 0.00
Other 0.83 0.70 0.54 0.47 1.00
Other long-term assets 4.62% 4.37% 6.24% 5.00% 4.02%
Long-term assets 82.26% 80.40% 78.25% 84.63% 80.94%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Boston Scientific Corp. current assets as a percentage of total assets decreased from 2020 to 2021 and from 2021 to 2022.
Property, plant and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Boston Scientific Corp. property, plant and equipment, net as a percentage of total assets increased from 2020 to 2021 and from 2021 to 2022.
Long-term assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Boston Scientific Corp. long-term assets as a percentage of total assets increased from 2020 to 2021 and from 2021 to 2022.